Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S212010, C514S408000, C514S315000, C514S218000, C514S252120, C514S385000
Reexamination Certificate
active
07105540
ABSTRACT:
The present invention provides novel methods of treating disorders of attention or improving attention in humans by administering an effective amount of a cholinesterase inhibitor.
REFERENCES:
patent: 5064858 (1991-11-01), Sapse et al.
patent: 6113879 (2000-09-01), Richards et al.
patent: 6455544 (2002-09-01), Friedhoff et al.
patent: WO 97/46527 (1997-12-01), None
Yamamoto et al. ‘Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic grugs,’ Behavioural brain research, Feb. 1997, vol. 83, pp. 57-62.
Mannuzza et al, “Adult Outcome of Hyperactive Boys,” Arch. Gen. Psychiatry, 50:565-576 (Jul. 1993).
Safer et al, “A Survey of Medication Treatment for Hyperactive/Inattentive Students,” JAMA, 260(15):2256-2258 (1988).
Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Text Revision, pp. 85-93 and 147-158 (2000).
Kirkby et al, Behavioural Pharmacology, 7:513-525 (1996).
Rogers et al, Dementia, 7(6):293-303 (1996).
Yamamoto et al, Behavioural Brain Research, 83:57-62 (1997).
Wray et al, W.I. Med. J., 30:107-118 (1981).
Anderson et al, Arch. Gen. Psychiatry, 44:69-76 (1987).
Deutsch, Science, 174:788-794 (1979).
Coyle et al, Science, 219:1184-1190 (1983).
Grady et al, Journal of Clinical and Experimental Neuropsychology, 10(5):576-596 (1988).
Amen, “When Your Child Can't Sit Still,” PARADE, Parade Publications (Jun. 2001).
Friedhoff Lawrence T.
Rogers Sharon L.
Tiseo Paul J.
Eisai Co. Ltd.
Venable LLP
Wang Shengjun
LandOfFree
Cholinesterase inhibitors to treat disorders of attention does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholinesterase inhibitors to treat disorders of attention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholinesterase inhibitors to treat disorders of attention will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3525401